Geoffrey Gilmartin
Publications by Year
Research Areas
Neuroscience of respiration and sleep, High Altitude and Hypoxia, Asthma and respiratory diseases, Obstructive Sleep Apnea Research, Heart Rate Variability and Autonomic Control
Most-Cited Works
- → Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial(2016)1,349 cited
- → Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial(2016)1,345 cited
- → Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation(2014)384 cited
- → Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)(2014)211 cited
- → Differentiating Obstructive from Central and Complex Sleep Apnea Using an Automated Electrocardiogram-Based Method(2007)182 cited
- → Recognition and management of complex sleep-disordered breathing(2005)144 cited
- → Clinical drug‐drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P‐glycoprotein(2014)56 cited
- → Treatment of Positive Airway Pressure Treatment-Associated Respiratory Instability with Enhanced Expiratory Rebreathing Space (EERS)(2010)53 cited
- → Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans(2008)51 cited
- → Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States(2015)49 cited